gliclazide has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, ER; Kim, W; Kim, YJ; Lee, CS; Myung, SC; Yang, JC | 1 |
| Bours, V; Gielen, J; Lechanteur, C; Merville, MP; Mesnil, M; Princen, F; Rigo, JM; Robe, P | 1 |
2 other study(ies) available for gliclazide and Adenocarcinoma
| Article | Year |
|---|---|
18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Drug Synergism; Enzyme Activation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mitochondria; Ovarian Neoplasms; Prodrugs; Tumor Suppressor Protein p53 | 2010 |
A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
Topics: 1-Octanol; Adenocarcinoma; Animals; Antiviral Agents; Cell Communication; Cell Survival; Colonic Neoplasms; Ganciclovir; Gap Junctions; Genetic Vectors; Glycyrrhetinic Acid; Herpesvirus 1, Human; Moloney murine leukemia virus; Rats; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1999 |